Morphine-conditioned single-trial place preference: Role of nucleus accumbens shell dopamine receptors in acquisition, but not expression

Psychopharmacology

Volumn 187, Issue 2, 2006, Pages 143-153

  Fenu, Sandro ^a   Spina, Liliana ^a   Rivas, Emilia ^a   Longoni, Rosanna ^a   Di Chiara, Gaetano ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

Author keywords

Conditioned place preference; Dopamine; Morphine; Motivation; Nucleus accumbens; Reward

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ECOPIPAM; MORPHINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG SPECIFICITY; MALE; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; TASK PERFORMANCE;

ANIMALS; ASSOCIATION LEARNING; BENZAZEPINES; BRAIN MAPPING; CHOICE BEHAVIOR; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; NARCOTICS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SOCIAL ENVIRONMENT; SULPIRIDE;

EID: 33745757130     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0415-2     Document Type: Article

References (63)

1. 1 receptor blockade stereo-specifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav Pharmacol 5:555-569
2. Acquas E, Carboni E, Leone P, Di Chiara G (1989) SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology 99:151-155
3. Baker DA, Khroyan TV, O'Dell LE, Fuchs RA, Neisewander JL (1996) Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference. J Pharmacol Exp Ther 279:392-401
4. Bardo MT, Neisewander JL (1986) Single-trial conditioned place preference using intravenous morphine. Pharmacol Biochem Behav 25:1101-1105
5. Bardo MT, Neisewander JL (1987) Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effect of morphine. Pharmacol Biochem Behav 28:267-273
6. Bardo MT, Neisewander JL, Miller JS (1986) Repeated testing attenuates conditioned place preference with cocaine. Psychopharmacology 89:239-243
7. Bardo MT, Valone JM, Bevins RA (1999) Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration. Psychopharmacology 143:39-46
8. Bardo MT, Gehrke BJ, Shortridge BE, Rauhut AS (2003) Effects of beta-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity. Pharmacol Biochem Behav 74:617-622
9. Bechara A, van der Kooy D (1992) Chronic exposure to morphine does not alter the neural tissues subserving its acute rewarding properties; apparent tolerance is overshadowing. Behav Neurosci 106:364-373
10. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309-369
11. Bozarth MA, Wise RA (1981) Heroin reward is dependent on a dopaminergic substrate. Life Sci 29:1881-1886
12. Calcagnetti DJ, Schechter MD (1994) Nicotine place preference using the biased method of conditioning. Prog Neuropsychopharmacol Biol Psychiatry 18:925-933
13. 3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology 97:175-178
14. Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ (eds) Oxford reviews in psychopharmacology: neuropharmacological basis of reward. Oxford University Press, New York, pp 264-319
15. Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A (1988) Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. J Pharmacol Exp Ther 247:1093-1102
16. Cunningham CL, Ferree NK, Howard MA (2003) Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology 170:409-422
17. Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137
18. Di Chiara G (1998) A motivational learning hypothesis of the role of dopamine in compulsive drug use. J Psychopharmacol 12:54-67
19. Di Chiara G (2000) Dopamine and reward. In: Di Chiara G (ed) Handbook of Experimental Pharmacology 154 'Dopamine in the CNS,' vol. II. Springer, Berlin Heidelberg New York, 299-319
20. Di Chiara G (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 137:75-114
21. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
22. Di Chiara G, Morelli M, Consolo S (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-233
23. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47:227-241
24. Dickinson A, Smith J, Mirenowicz J (2000) Dissociation of Pavlovian and instrumental incentive learning under dopamine antagonists. Behav Neurosci 114:468-483
25. Duffy RA, Hunt MA, Wamsley JK, McQuade RD (2000) In vivo autoradiography of [3H]SCH 39166 in rat brain: selective displacement by D1/D5 antagonists. J Chem Neuroanat 19:41-46
26. Ettenberg A (1990) Haloperidol prevents the reinstatement of amphetamine-rewarded runway responding in rats. Pharmacol Biochem Behav 36:635-638
27. Ettenberg A, McFarland K (2003) Effects of haloperidol on cue-induced autonomic and behavioral indices of heroin reward and motivation. Psychopharmacology 168:139-145
28. 1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci 21:6897-6904
29. Hoffman DC (1989) The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23:373-387
30. Horvitz JC, Ettenberg A (1988) Haloperidol blocks the response-reinstating effects of food reward: a methodology for separating neuroleptic effects on reinforcement and motor processes. Pharmacol Biochem Behav 31:861-865
31. Horvitz JC, Ettenberg A (1991) Conditioned incentive properties of a food-paired conditioned stimulus remain intact during dopamine receptor blockade. Behav Neurosci 105:536-541
32. 2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17:8580-8587
33. Le Foll B, Goldberg SR (2005) Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178:481-492
34. 1 receptors by SCH 23390 antagonizes morphine and amphetamine induced place preference conditioning. Eur J Pharmacol 135:251-254
35. Liu ZH, Jin WQ, Zhang HP, Chen XJ, Jin GZ (2003) Suppression of morphine-induced place preference by 1-12-chloroscoulerine, a novel dopamine receptor ligand. Pharmacol Biochem Behav 75:289-294
36. Mackey WB, van der Kooy D (1985) Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol Biochem Behav 22:101-105
37. Maldonado R, Salardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586-589
38. Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J (2001) Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 121:189-197
39. McFarland K, Ettenberg A (1995) Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin. Psychopharmacology 122:346-350
40. McFarland K, Ettenberg A (1998) Haloperidol does not affect motivational processes in an operant runway model of food-seeking behavior. Behav Neurosci 112:630-635
41. McFarland K, Ettenberg A (1999) Haloperidol does not attenuate conditioned place preferences or locomotor activation produced by food- or heroin-predictive discriminative cues. Pharmacol Biochem Behav 62:631-641
42. Mucha RF, van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91-105
43. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, San Diego, USA
44. Phillips AG, Pfaus JG, Blaha CD (1991) Dopamine and motivated behavior: insights provided by in vivo analysis. In: Willner P, Scheel-Kruger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, UK, pp 199-224
45. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308
46. 2 receptors of the central amygdala on the acquisition and expression of morphine-induce place preference in rat. Pharmacol Biochem Behav 74:187-197
47. Robbins TW (2005) Role of cortical and striatal dopamine in cognitive function. In: Dunnett SB, Bentivoglio M, Bjorklund A, Hokfelt T (eds) Dopamine, handbook of chemical neuroanatomy, vol. 21. Elsevier, Amsterdam, pp 395-434
48. Robbins TW, Cador M, Taylor JR, Everitt BJ (1989) Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev 13:155-162
49. Salamone JD (1992) Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacology 107:160-174
50. Salamone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21:341-359
51. Schwartz AS, Marchok PL (1974) Depression of morphine-seeking behaviour by dopamine inhibition. Nature 248:257-258
52. Sellings LH, Clarke PB (2003) Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci 23:6295-6303
53. 1 dopamine receptors in the motivational properties of μ- and κ-opioid agonists. Brain Res 436:169-172
54. 2 receptor antagonists. Eur J Pharmacol 151:233-242
55. Shippenberg TS, Bals-Kubik R, Huber A, Herz A (1991) Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology 103:209-214
56. 2 dopamine receptors. J Pharmacol Exp Ther 265:53-59
57. Smith JW, Fetsko LA, Xu R, Wang Y (2002) Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience 113:755-765
58. Spina L, Fenu S, Longoni R, Rivas E, Di Chiara G (2006) Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology 184(3-4):447-455
59. Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroine reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278-283
60. Suzuki T, Misawa M (1995) Sertindole antagonizes morphine-, cocaine- and methamphetamine-induced place preference in the rat. Life Sci 57:1277-1284
61. Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1993) Morphine induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtypes. Brain Res 602:45-52
62. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672
63. Wise RA (1982) Neuroleptics and operant behaviour: the anhedonia hypothesis. Behav Brain Sci 5:39-87